Xponance, Inc. Balchem Corp Transaction History

Xponance, Inc.

$10.2 Billion
Q3 2024

A detailed history of Xponance, Inc. transactions in Balchem Corp stock. As of the latest transaction made, Xponance, Inc. holds 2,122 shares of BCPC stock, worth $372,177. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,122

Previous 2,046 3.71%

Holding current value

$372,177

Previous $314,000 18.79%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$154.1 - $181.56 $11,711 - $13,798	76 Added 3.71%	2,122 $373,000
Q2 2024 Aug 14, 2024	BUY	$138.5 - $156.63 $14,127 - $15,976	102 Added 5.25%	2,046 $314,000
Q1 2024 May 13, 2024	BUY	$137.06 - $157.27 $959 - $1,100	7 Added 0.36%	1,944 $301,000
Q4 2023 Jan 31, 2024	BUY	$115.08 - $150.35 $4,718 - $6,164	41 Added 2.16%	1,937 $288,000
Q3 2023 Oct 23, 2023	BUY	$123.38 - $142.72 $1,727 - $1,998	14 Added 0.74%	1,896 $235,000
Q2 2023 Jul 13, 2023	BUY	$122.28 - $136.64 $4,157 - $4,645	34 Added 1.84%	1,882 $253,000
Q1 2023 Apr 17, 2023	BUY	$117.39 - $142.06 $2,817 - $3,409	24 Added 1.32%	1,848 $233,000
Q4 2022 Jan 23, 2023	BUY	$120.16 - $142.73 $4,566 - $5,423	38 Added 2.13%	1,824 $0
Q3 2022 Oct 24, 2022	BUY	$119.7 - $141.48 $7,182 - $8,488	60 Added 3.48%	1,786 $217,000
Q2 2022 Aug 02, 2022	BUY	$113.6 - $139.82 $21,584 - $26,565	190 Added 12.37%	1,726 $224,000
Q1 2022 Apr 20, 2022	BUY	$131.21 - $167.55 $1,312 - $1,675	10 Added 0.66%	1,536 $210,000
Q4 2021 Jan 31, 2022	BUY	$149.18 - $172.5 $1,044 - $1,207	7 Added 0.46%	1,526 $257,000
Q3 2021 Nov 05, 2021	SELL	$129.2 - $150.61 $31,912 - $37,200	-247 Reduced 13.99%	1,519 $220,000
Q2 2021 Aug 12, 2021	BUY	$119.87 - $133.92 $211,690 - $236,502	1,766 New	1,766 $232,000

Others Institutions Holding BCPC

# of Institutions

374

Shares Held

28.3M

Call Options Held

267K

Put Options Held

5.7K

View Full List

About BALCHEM CORP

Ticker BCPC
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 32,120,600
Market Cap $5.63B
Description
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal N...

More about BCPC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account